Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled vs Oral Morphine for Breakthrough Cancer Pain
NCT00020618Phase 2Completed
- Sponsor
- Dana-Farber Cancer Institute
- Start
- Mar 2001
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of morphine in breakthrough pain, sponsored by Dana-Farber Cancer Institute. Started Mar 2001; status: completed.
02
Drugs
morphine
03
Conditions
breakthrough pain
Beyond the preview
Go deeper on NCT00020618.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00020618.